See attached file(s)Specifically, I believe regulation of Mycotoxins in
general, and Aflatoxin in particular, will provide
substantial public health benefits.
Aflatoxin is a fungal toxin produced by Aspergillus
and Penicillium fungi, and is a complex aromatic
hetero-cycle, decomposing at 561F. Aflatoxin has been
shown to survive in Environmental tobacco smoke.
Aspergillus is found worldwide as a storage fungus
and production is favored by heat and humidity. Aflatoxin
has been regulated by the FDA on all agricultural
commodities such as milk, corn, grains and peanuts
since 1966, but surprisingly, not on tobacco. There is
irrefutable evidence for contamination of tobacco by
aflatoxin which is beyond the scope of my comments today.
The documents proving this can be found by
viewing my submitted comments. Hundreds of internal
documents discovered in tobacco litigation along with
others give us insight into the work done in this area from
the 1960s through today.
More recently p53tumor suppressor gene research is
evidence of aflatoxin contamination of tobacco. P53 is the
“Guardian of the Genome” which instructs genetically
damaged cells to repair or die. P53 is the most common
mutation in all cancers and most laboratory cancer
experiments use aflatoxin to mutate p53 as a positive
control. The World Health Organization-IARC database
analysis shows substantial mutations in human cancers
consistent with an aflatoxin etiology. Most cancers show
p53 mutations, especially Lung, Breast, and others. These
may be due to Aflatoxin-chemically a benzopyran- or to
combustion of Aflatoxin- leading to Benzpyrene.
Significantly, Aflatoxin is 200 times more carcinogenic
than Benzpyrene, also a recognized tobacco carcinogen.
Acting alone, aflatoxin, or fungal toxigenic spores which
are semi-fire resistant, may produce toxins in vivo, acting
as infectious cancer foci. Focal Aspergillus spores
producing AFB would mutate p53 while Gliotoxin
produced
Kerry Scott Lane, MD - Comment
This is comment on Notice
Tobacco Product Manufacturing Practice; Establishment of a Public Docket
View Comment
Attachments:
Extract from United States Patent 6058940
Title:
Extract from United States Patent 6058940
Related Comments
View AllPublic Submission Posted: 03/19/2013 ID: FDA-2013-N-0227-0002
May 20,2013 11:59 PM ET
Public Submission Posted: 05/22/2013 ID: FDA-2013-N-0227-0008
May 20,2013 11:59 PM ET
Public Submission Posted: 05/17/2013 ID: FDA-2013-N-0227-0005
May 20,2013 11:59 PM ET
Public Submission Posted: 05/22/2013 ID: FDA-2013-N-0227-0013
May 20,2013 11:59 PM ET
Public Submission Posted: 05/17/2013 ID: FDA-2013-N-0227-0004
May 20,2013 11:59 PM ET